Cargando…
GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings
Here, we studied the anti-glioma cell activity by a novel AMP-activated protein kinase (AMPK) activator GSK621. We showed that GSK621 was cytotoxic to human glioma cells (U87MG and U251MG lines), possibly via provoking caspase-dependent apoptotic cell death. Its cytotoxicity was alleviated by caspas...
Autores principales: | Jiang, Hong, Liu, Wei, Zhan, Shi-Kun, Pan, Yi-Xin, Bian, Liu-Guan, Sun, Bomin, Sun, Qing-Fang, Pan, Si-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988667/ https://www.ncbi.nlm.nih.gov/pubmed/27532105 http://dx.doi.org/10.1371/journal.pone.0161017 |
Ejemplares similares
-
Tetraspanin 8-Rictor-Integrin α3 Complex Is Required for Glioma Cell Migration
por: Pan, Si-Jian, et al.
Publicado: (2015) -
Targeted activation of AMPK by GSK621 ameliorates H(2)O(2)-induced damages in osteoblasts
por: Liu, Weidong, et al.
Publicado: (2017) -
The therapeutic value of XL388 in human glioma cells
por: Zhong, Shan, et al.
Publicado: (2020) -
Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7
por: Pan, Si-Jian, et al.
Publicado: (2015) -
Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma
por: Oh, Jinsoo, et al.
Publicado: (2017)